Veterinary Medicines

IZOVAC ND IB IBD REO

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
  • Avian reovirus, strain S1133, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
IZOVAC ND IB IBD REO
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
  • Avian reovirus, strain S1133, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Avian reovirus, strain S1133, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Newcastle disease virus, strain Ulster, Inactivated
    16.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    64.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA16
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/08/2024
Download